Envestnet Asset Management Inc Exagen Inc. Transaction History

Envestnet Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$2.69 - $8.68 $6,625 - $21,378	-2,463 Reduced 9.43%	23,665 $64,000
Q2 2022 Aug 03, 2022	BUY	$4.18 - $7.74 $1,659 - $3,072	397 Added 1.54%	26,128 $150,000
Q1 2022 May 04, 2022	BUY	$7.12 - $11.06 $13,093 - $20,339	1,839 Added 7.7%	25,731 $207,000
Q4 2021 Feb 04, 2022	SELL	$8.97 - $14.08 $21,985 - $34,510	-2,451 Reduced 9.3%	23,892 $278,000
Q3 2021 Oct 07, 2021	SELL	$10.25 - $15.21 $21,986 - $32,625	-2,145 Reduced 7.53%	26,343 $358,000
Q2 2021 Aug 04, 2021	SELL	$12.4 - $17.92 $13,999 - $20,231	-1,129 Reduced 3.81%	28,488 $427,000
Q1 2021 May 04, 2021	BUY	$13.9 - $22.0 $411,676 - $651,574	29,617 New	29,617 $518,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.